Syschem (India)

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE121D01036
  • NSEID:
  • BSEID: 531173
INR
45.88
0.38 (0.84%)
BSENSE

Jun 18

BSE+NSE Vol: 10.44 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Ambalal Sarabhai
Quest Laborato.
Syschem (India)
Aarey Drugs
Brooks Lab.
Sanjiv.Parant.
Nectar Lifesci.
Kerala Ayurveda
Accretion Nutrav
Speciality Medi.
Sat Kartar Life
Why is Syschem (India) Ltd ?
1
Poor Management Efficiency with a low ROE of 8.92%
  • The company has been able to generate a Return on Equity (avg) of 8.92% signifying low profitability per unit of shareholders funds
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.09 times
3
Healthy long term growth as Net Sales has grown by an annual rate of 52.98%
4
With a growth in Operating Profit of 388.02%, the company declared Outstanding results in Mar 26
  • The company has declared positive results for the last 6 consecutive quarters
  • PAT(Q) At Rs 1.74 cr has Grown at 278.3%
  • PBDIT(Q) Highest at Rs 9.37 cr.
  • OPERATING PROFIT TO NET SALES(Q) Highest at 4.27%
5
Stock is technically in a Mildly Bearish range
  • The technical trend has deteriorated from on
  • The stocks MACD and Bollinger Band technical factors are also Bearish
6
With ROE of 10, it has a Attractive valuation with a 2.4 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -0.55%, its profits have risen by 902% ; the PEG ratio of the company is 0
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Syschem (India) should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Syschem (India) for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Syschem (India)
0.09%
-0.01
43.62%
Sensex
-5.08%
-0.38
13.26%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
52.98%
EBIT Growth (5y)
33.67%
EBIT to Interest (avg)
3.34
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.05
Sales to Capital Employed (avg)
4.32
Tax Ratio
35.84%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.16%
ROCE (avg)
-3.19%
ROE (avg)
8.92%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
24
Industry P/E
42
Price to Book Value
2.35
EV to EBIT
12.84
EV to EBITDA
10.36
EV to Capital Employed
2.42
EV to Sales
0.38
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
6.37%
ROE (Latest)
9.99%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

36What is working for the Company
PAT(Q)

At Rs 1.74 cr has Grown at 278.3%

PBDIT(Q)

Highest at Rs 9.37 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 4.27%

PBT LESS OI(Q)

Highest at Rs 5.60 cr.

NET SALES(Q)

Highest at Rs 219.35 cr

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Syschem (India)
Net Sales - Quarterly
At Rs 219.35 cr has Grown at 84.53%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 5.60 cr has Grown at 465.66%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 1.74 cr has Grown at 278.3%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 9.37 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 4.27% and Grown
each quarter in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 5.60 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Net Sales - Quarterly
Highest at Rs 219.35 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)